ERYTHROMYCIN ESTOLATE

ERYTHROMYCIN ESTOLATE is a lipid of Polyketides (PK) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 675 references associated with ERYTHROMYCIN ESTOLATE in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for ERYTHROMYCIN ESTOLATE

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with ERYTHROMYCIN ESTOLATE

MeSH term MeSH ID Detail
Otitis Media D010033 12 associated lipids
Body Weight D001835 333 associated lipids
Whooping Cough D014917 6 associated lipids
Fecal Impaction D005244 1 associated lipids
Total 4

All references with ERYTHROMYCIN ESTOLATE

Download all related citations
Per page 10 20 50 100 | Total 98
Authors Title Published Journal PubMed Link
REED C and RITCHIE F Toxic jaundice due to propionyl erythromycin ester lauryl sulphate ("Ilosone"). 1962 Med. J. Aust. pmid:14037477
BROWN AR TWO CASES OF UNTOWARD REACTION AFTER "ILOSONE". 1963 Br Med J pmid:14067683
GRIFFITH RS and BLACK HR COMPARISON OF THE BLOOD LEVELS OBTAINED AFTER SINGLE AND MULTIPLE DOSES OF ERYTHROMYCIN ESTOLATE AND ERYTHROMYCIN STEARATE. 1964 Am. J. Med. Sci. pmid:14106882
FISCHER HW and HOAK JC MIMICRY OF ACUTE CHOLECYSTITIS BY ERYTHROMYCIN ESTOLATE REACTIONS. REPORT OF 2 CASES. 1964 Am. J. Med. Sci. pmid:14130320
SOUTH MA et al. FAILURE OF ERYTHROMYCIN ESTOLATE THERAPY IN IN UTERO SYPHILIS. 1964 JAMA pmid:14197148
Bellomo-Brandão MA et al. Use of erythromycin for the treatment of severe chronic constipation in children. 2003 Braz. J. Med. Biol. Res. pmid:14502372
Saiz Santos S and Montero López L [Hepatotoxicity from erythromycin estolate]. 1992 Aten Primaria pmid:1467424
Pari L and Uma A Protective effect of Sesbania grandiflora against erythromycin estolate-induced hepatotoxicity. 2003 Sep-Oct Therapie pmid:14682193
Park SJ and Kim SH Preparation and characterization of biodegradable poly(l-lactide)/poly(ethylene glycol) microcapsules containing erythromycin by emulsion solvent evaporation technique. 2004 J Colloid Interface Sci pmid:14972610
Pari L and Murugan P Protective role of tetrahydrocurcumin against erythromycin estolate-induced hepatotoxicity. 2004 Pharmacol. Res. pmid:14998559

Table of Content